secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-06-01T11:30:18+00:00
Accession:  0001493152-26-026529
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance
--------------------------------------------------------------------------------

- Must demonstrate bid price at or above $1 for 20 consecutive trading days by July 29, 2026.
- If deficient before September 22, 2026, Company will be immediately delisted.
- Non-compliance with any other listing rule before Sep 22 gives 7 days to advise panel.
- Regaining compliance will result in a Discretionary Panel Monitor for one year.
- Company's hearing was on May 5, 2026; panel granted extension on May 29, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/0001493152-26-026529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer